## Situation Report
The US Department of Defense has funded over 120 biolaboratories in 30 countries worldwide, according to a 2020 report by the DTRA (Defense Threat Reduction Agency) [Intel Slava, 2020].
These biolaboratories are part of the US government's Cooperative Biological Engagement Program (CBEP), which aims to prevent the spread of biological threats in partner countries.
## Strategic Context
The Ukraine theater has seen increased tensions between Russia and the West, particularly in the wake of the 2022 Russian invasion. The US has maintained a significant military presence in Eastern Europe, with a focus on supporting Ukraine's defense against Russian aggression.
## Geopolitical Implications
The existence of US-funded biolaboratories in Ukraine and other countries has raised concerns about the potential for biological warfare and the risk of accidents or intentional releases of pathogens. This development may escalate tensions between Russia and the West, particularly if Russia perceives these laboratories as a threat to its national security.